14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
CNMD vs KTWO: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, CONMED Corporation (CNMD) is the stronger overall head-to-head candidate over KTWO (KTWO) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CNMD carries a Unified Composite Score of 49.1/100 (HOLD) at $46.56 (9.8x Forward P/E, 10.2% operating margin), whereas KTWO carries 55.8/100 (HOLD) at $10.12 (N/M Forward P/E, N/A operating margin).
Composite vs. Pillar Nuance: While KTWO currently prints a higher short-term Unified Composite Score (55.8/100 HOLD vs. CNMD 49.1/100 HOLD), CNMD captures the overall institutional head-to-head verdict (7–3 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (10.2% vs. N/A operating margin) and revenue trajectory (-0.7% vs. N/A YoY).
Technical & Structure Timing Caution: CNMD is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 42.7); meanwhile KTWO trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 57.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CNMD vs KTWO. Trailing 12-month operating profitability (CNMD 10.2% vs KTWO N/A) and valuation multiples (CNMD 9.8x vs KTWO N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ CNMD vs KTWO Key Questions & Quantitative Answers
As of Nov 20, 2026, CONMED Corporation (CNMD) is the stronger overall head-to-head candidate over KTWO (KTWO) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CNMD carries a Unified Composite Score of 49.1/100 (HOLD) at $46.56 (9.8x Forward P/E, 10.2% operating margin), whereas KTWO carries 55.8/100 (HOLD) at $10.12 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While KTWO currently prints a higher short-term Unified Composite Score (55.8/100 HOLD vs. CNMD 49.1/100 HOLD), CNMD captures the overall institutional head-to-head verdict (7–3 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (10.2% vs. N/A operating margin) and revenue trajectory (-0.7% vs. N/A YoY). Technical & Structure Timing Caution: CNMD is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 42.7); meanwhile KTWO trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 57.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
CNMD leads the Growth & Scale pillar: CNMD posts -0.7% YoY revenue growth and +633.3% YoY earnings growth on $1.37B TTM revenue (54.8% gross margin, 10.2% operating margin), compared with KTWO at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, CNMD generates $1.37B in USD-normalized revenue versus N/A for KTWO. In operating R&D and SG&A reinvestment, CNMD deploys 44.6% of Rev ($611M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for KTWO.
CNMD screens cheaper on headline valuation multiples. CNMD trades at 9.8x Forward P/E, 19.2x Trailing P/E, 1.84x PEG, and 1.6x EV/Revenue (9.7% FCF margin), whereas KTWO trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CNMD (7.1% ROE) versus KTWO (N/A ROE) capital efficiency.
In options market volatility and institutional positioning, CNMD carries 35.6% implied volatility (2nd %ile, Compressed (<25th %ile)), a 0.07x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.82β · 58% Vol realized risk). By comparison, KTWO carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.02β · 4% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.